OMG Adopts FIGI Identifier Standard
Standards consortium recognizes instrument identifier

Technology standards consortium the Object Management Group (OMG) has officially adopted the Financial Instrument Global Identifier (FIGI).
The FIGI initiative is backed by Bloomberg and is based on the company's Open Symbology system, developed for identifying securities across all global asset classes. However, the FIGI is non-proprietary, is issued under an MIT License and is intended to be used free of charge by data and software vendors, exchanges, regulators and market participants.
"The OMG recently released the FIGI as an industry standard for use by industry practitioners in the capital markets, which lacks a universal system for identifying and describing financial instruments," says Richard Soley, chairman and CEO of OMG.
"A game-changing standard, the FIGI ties together disparate and fragmented symbologies, eliminates redundant mapping processes, streamlines the trade workflow and reduces operational risk."
A press release adds that the FIGI has been added to the extended code set for ISO 20022 messages, and can therefore be used for instrument identification in all ISO 20022 messaging, including over the Swift network.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@waterstechnology.com
More on Trading Tech
Asset manager Fortlake turns to AI data mapping for derivatives reporting
The firm also intends to streamline the data it sends to its administrator and establish a centralized database with the help of Fait Solutions.
The murky future of buying or building trading technology
Waters Wrap: It’s obvious the buy-v-build debate is changing as AI gets more complex, but Anthony wonders how trading firms will keep up.
FactSet lays out trading roadmap post LiquidityBook deal
The software and data provider announced it was buying LiquidityBook this month, filling a gap in its front-office suite of solutions.
BlackRock tests ‘quantum cognition’ AI for high-yield bond picks
The proof of concept uses the Qognitive machine learning model to find liquid substitutes for hard-to-trade securities.
The future of trading takes shape
The future of trading across the capital markets and the drivers likely to shape the ever-evolving industry
On GenAI, Citi moves from firm-wide ban to internal roll-out
The bank adopted three specific inward-facing use cases with a unified framework behind them.
FactSet-LiquidityBook: The buy-side OMS space continues to shrink
Waters Wrap: Anthony spoke with buy-side firms and industry experts to get a feel for how the market is reacting to this latest tie-up.
Examining Cboe’s lawsuit appealing SEC’s OEMS rule rejection
The Chicago-based exchange has sued the regulator in the Seventh Circuit Court of Appeals after the agency blocked a proposed rule that would change how Silexx is classified.